Atlas Trials

Secondary Hyperparathyroidism Due to Renal Causes

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Secondary Hyperparathyroidism Due to Renal Causes

RecordFirmDate
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI (NCT03602261)OPKO Health, Inc.2018-07-09
Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency (NCT03588884)OPKO Health, Inc.2018-06-08
Pulmonary Function, Voice and Swallowing Symptoms After Parathyroidectomy (NCT04267965)Chang Gung Memorial Hospital2017-08-01
Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. (NCT01939977)Fundación Senefro2014-01-01

Track Secondary Hyperparathyroidism Due to Renal Causes automatically

Every clearance here is in the API, with alerts when new ones post.